Skip to Content




ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiviral agent


Chemical Name

1H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-metylpropyl)-

Foreign Names

  • Imiquimodum (Latin)
  • Imiquimod (German)
  • Imiquimod (French)
  • Imiquimod (Spanish)

Generic Names

  • Imiquimod (OS: USAN, BAN, DCF, JAN)
  • R 837 (IS)
  • S 26308 (IS)
  • Zartra (IS)
  • Imiquimod (PH: USP 38)

Brand Names

  • Aldara
    3M, China; 3M, Georgia; 3M, Kenya; 3M, Oman; 3M, Serbia; 3M Health Care, Israel; 3M Health Care, Lebanon; Bausch & Lomb Pharma, Thailand; Dong-A, South Korea; GlaxoSmithKline, China; iNova, Australia; iNova, Hong Kong; iNova, Malaysia; iNova, New Zealand; iNova, Philippines; iNova, South Africa; Laboratorios Euromed Chile, Chile; Meda, Bosnia & Herzegowina; Meda, Belgium; Meda, Denmark; Meda, Hungary; Meda, Ireland; Meda, Iceland; Meda, Italy; Meda, Lithuania; Meda, Latvia; Meda, Norway; Meda, Poland; Meda, Portugal; Meda, Romania; Meda, Sweden; Meda, Turkey; Meda Pharm, Greece; Meda Pharma, Czech Republic; Meda Pharma, Slovakia; Meda Pharma Sau, Spain; Medical Intertrade, Croatia (Hrvatska); Medicis Dermatologics, United States; More Pharma Corporation, Costa Rica; More Pharma Corporation, Guatemala; More Pharma Corporation, Honduras; More Pharma Corporation, Panama; More Pharma Corporation, El Salvador; Valeant Canada, Canada
  • Aldara 5%
    Meda, Austria; Meda, Finland; Meda, France; Meda, Slovenia; MEDA Pharma, Switzerland; Meda Pharmaceuticals, Cyprus; Meda Pharmaceuticals, United Kingdom; Mediwin, France
  • Apo-Imiquimod
    Apotex, Australia; Apotex, Canada
  • Aquimod
    Taro, Israel
  • Beselna 5%
    Mochida Pharmaceutical, Japan
  • Imicare
    Medinfar, Portugal
  • Imik
    Lafrancol, Colombia
  • Imimore
    Panalab, Argentina; Panalab, Peru
  • Imiquad
    Glenmark, India
  • Imunocare
    Difa Cooper, Italy
  • Labimiq 5%
    ITF - Labomed Farmaceutica, Chile
  • Li Di
    Mingxin Pharmaceutical, China
  • Li Ke Jie
    Keyi Pharmaceutical, China
  • Mandikoz
    Glenmark Pharmaceuticals, Mexico
  • Miquimod
    Lazar, Argentina; Lazar, Ecuador
  • Modulcass
    Cassara, Argentina
  • Nan Bo
    Topfond Pharmaceutical, China
  • Nilwart
    Dr. Reddy's, India
  • Perrimod
    Perrigo, Israel
  • Quimara-1
    Liomont, Mexico
  • Quinilan
    LKM, Argentina
  • Tian Rui
    Yangtze River Pharma, China
  • Virosupril
    Medihealth, Colombia; Raymos, Argentina
  • Vyloma
    Valeant Canada, Canada
  • You Care
    Nang Kuang, Taiwan
  • Youbiqing
    The United Laboratories Ltd, China
  • Zyclara
    Meda, Denmark; Meda, Lithuania; Meda, Norway; Meda, Poland; Meda, Portugal; Meda, Sweden; MEDA Pharma, Switzerland; MEDA Pharma, Germany; Medicis Dermatologics, United States; UCB Pharma, Latvia; Valeant Pharmaceuticals International, Canada
  • Zyclara 3,75%
    Meda, Austria; Meda, Ireland
  • Zyclara 3.75%
    Meda, Finland; Meda Pharmaceuticals, United Kingdom


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.